These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1798073)
1. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. I. Synergistic action with minocycline]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R Jpn J Antibiot; 1991 Dec; 44(12):1386-91. PubMed ID: 1798073 [TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of cefodizime in combination with minocycline against systemic infection caused by methicillin-resistant Staphylococcus aureus in immunocompromised tumour bearing mice]. Furukawa T; Shimizu C; Uji T; Miyake Y; Hyodo A; Deguchi K Jpn J Antibiot; 1993 Apr; 46(4):310-7. PubMed ID: 8515562 [TBL] [Abstract][Full Text] [Related]
3. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. II. Synergistic actions of cefotiam with arbekacin and minocycline]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R Jpn J Antibiot; 1993 Feb; 46(2):123-9. PubMed ID: 8331772 [TBL] [Abstract][Full Text] [Related]
4. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. I. Cefotiam plus minocycline]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R Jpn J Antibiot; 1992 Jun; 45(6):597-604. PubMed ID: 1507393 [TBL] [Abstract][Full Text] [Related]
5. [Synergistic action of cefodizime with other antimicrobial agents on clinically isolated microorganisms. II. Synergistic action with sisomicin]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R Jpn J Antibiot; 1992 Jan; 45(1):1-11. PubMed ID: 1495193 [TBL] [Abstract][Full Text] [Related]
6. [Bacteriological evaluations of combination therapies with minocycline and beta-lactams for methicillin-resistant Staphylococcus aureus. II. cefuzonam plus minocycline]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R Jpn J Antibiot; 1992 Jun; 45(6):605-11. PubMed ID: 1507394 [TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field. Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174 [TBL] [Abstract][Full Text] [Related]
9. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefotiam in combination against methicillin-susceptible and -resistant Staphylococcus aureus studied using checkerboard MIC method and disc diffusion method with discs containing both drugs]. Matsuo K; Uete T Jpn J Antibiot; 1993 Mar; 46(3):222-33. PubMed ID: 8510319 [TBL] [Abstract][Full Text] [Related]
10. [Annual changes in isolation of MRSA in our department and chemotherapeutic effect of antibiotics including minocycline against postoperative infections of methicillin-resistant S. aureus]. Yokoyama T; Kodama T; Takesue Y; Fujimoto M; Murakami Y; Sewake H; Imamura Y; Okita M Jpn J Antibiot; 1990 Jan; 43(1):131-8. PubMed ID: 2348549 [TBL] [Abstract][Full Text] [Related]
11. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. IV. Synergistic action with dibekacin]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R Jpn J Antibiot; 1992 May; 45(5):478-88. PubMed ID: 1512933 [TBL] [Abstract][Full Text] [Related]
12. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. III. Synergistic action with gentamicin]. Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R Jpn J Antibiot; 1992 May; 45(5):468-77. PubMed ID: 1512932 [TBL] [Abstract][Full Text] [Related]
13. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs]. Matsuo K; Uete T Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773 [TBL] [Abstract][Full Text] [Related]
14. [Antibacterial activity of norfloxacin on methicillin-resistant Staphylococcus aureus. Comparison with oral antibacterial agents]. Iwata S; Kawashima C; Sakamoto H; Isohata E; Kin Y; Yokota T; Kusumoto Y; Sato Y; Akita H; Oikawa T Jpn J Antibiot; 1990 Feb; 43(2):228-32. PubMed ID: 2362350 [TBL] [Abstract][Full Text] [Related]
15. [Susceptibility and beta-lactamase-producing strains of methicillin-resistant Staphylococcus aureus]. Akimoto Y; Kaneko K; Fujii A Nichidai Koko Kagaku; 1989 Sep; 15(3):338-41. PubMed ID: 2489806 [TBL] [Abstract][Full Text] [Related]
16. [Influence of Mueller-Hinton broth on the in vitro activities of cefuzoname, flomoxef, imipenem, and minocycline against Staphylococcus aureus]. Fujita S; Tonohata A Jpn J Antibiot; 1990 May; 43(5):757-60. PubMed ID: 2391746 [TBL] [Abstract][Full Text] [Related]
18. Hamza M; Nadir M; Mehmood N; Farooq A Indian J Pharmacol; 2016; 48(6):710-714. PubMed ID: 28066112 [TBL] [Abstract][Full Text] [Related]
19. [Bacteriological evaluations of combination effects with cefotiam and other antimicrobial agents against methicillin-resistant Staphylococcus aureus. I. Synergistic actions of cefotiam with imipenem and vancomycin]. Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R Jpn J Antibiot; 1993 Feb; 46(2):115-22. PubMed ID: 8331771 [TBL] [Abstract][Full Text] [Related]
20. Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus. Low DE; Kreiswirth BN; Weiss K; Willey BM Int J Antimicrob Agents; 2002 Sep; 20(3):220-2. PubMed ID: 12385702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]